Lataa...
Pharmacogenetics and Clopidogrel Response in Patients Undergoing Percutaneous Coronary Interventions
A 62-year-old presents with angina. He has been genotyped for a panel of drug metabolism enzymes through a direct-to-consumer genetics company. His results reveal a CYP2C19 *2/*2 genotype with a warning that poor metabolizers (PMs) may have “lack of therapeutic effect of clopidogrel (Plavix), result...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2011
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3235907/ https://ncbi.nlm.nih.gov/pubmed/21270785 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/clpt.2010.316 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|